
Abiomed ABMD
Quarterly report 2022-Q3
added 11-03-2022
Abiomed P/E Ratio 2011-2026 | ABMD
Annual P/E Ratio Abiomed
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.0719 | 42.6 | 48.1 | 118 | 108 | 107 | 22.6 | 127 | 48.1 | 625 | -55 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 625 | -55 | 108 |
P/E Ratio of other stocks in the Medical devices industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
-0.226 | $ 2.22 | 5.21 % | $ 3.47 M | ||
|
AdaptHealth Corp.
AHCO
|
-17 | $ 10.45 | 0.29 % | $ 1.41 B | ||
|
Allied Healthcare Products
AHPI
|
-2.07 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-50 | - | - | $ 1.77 B | ||
|
Cognyte Software Ltd.
CGNT
|
-54.8 | $ 8.36 | -0.24 % | $ 600 M | ||
|
Acutus Medical
AFIB
|
-0.0641 | - | -26.83 % | $ 2.62 M | ||
|
CONMED Corporation
CNMD
|
28 | $ 37.34 | -0.16 % | $ 1.16 B | ||
|
Lianluo Smart Limited
LLIT
|
-45.2 | - | 24.59 % | $ 44.8 M | ||
|
Butterfly Network
BFLY
|
-10.6 | $ 4.27 | 9.21 % | $ 904 M | ||
|
Alphatec Holdings
ATEC
|
-14.4 | $ 13.05 | 3.57 % | $ 1.96 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-2.84 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
-0.714 | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
-0.142 | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
-0.00929 | - | -13.19 % | $ 166 K | ||
|
Establishment Labs Holdings
ESTA
|
-45.3 | $ 65.01 | 2.41 % | $ 1.93 B | ||
|
Boston Scientific Corporation
BSX
|
39 | $ 71.2 | 2.02 % | $ 105 B | ||
|
Conformis
CFMS
|
-0.25 | - | - | $ 16.4 M | ||
|
Cytosorbents Corporation
CTSO
|
-2.63 | $ 0.68 | 4.61 % | $ 37 M | ||
|
EDAP TMS S.A.
EDAP
|
-3.16 | $ 4.06 | 2.53 % | $ 151 M | ||
|
Apollo Endosurgery
APEN
|
-10.1 | - | - | $ 475 M | ||
|
Cutera
CUTR
|
-0.813 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
-54.3 | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
-0.179 | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
-24.6 | $ 11.16 | 1.18 % | $ 302 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0578 | - | 1.15 % | $ 34.5 M | ||
|
IRIDEX Corporation
IRIX
|
-5.02 | $ 1.33 | - | $ 21.5 M | ||
|
Axonics Modulation Technologies
AXNX
|
-47.3 | - | - | $ 3.31 B | ||
|
Soliton, Inc.
SOLY
|
-15.7 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-875 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-31 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-10.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-27.2 | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
6.85 | $ 18.45 | 0.16 % | $ 121 M | ||
|
Helius Medical Technologies
HSDT
|
-0.4 | $ 2.17 | -0.91 % | $ 1.32 M | ||
|
LivaNova PLC
LIVN
|
-15.7 | $ 62.43 | 1.63 % | $ 3.41 B | ||
|
GBS
GBS
|
-0.235 | - | -0.57 % | $ 7.12 M | ||
|
InMode Ltd.
INMD
|
9.89 | $ 13.65 | 1.64 % | $ 882 M | ||
|
MiMedx Group
MDXG
|
16 | $ 4.36 | -1.13 % | $ 644 M | ||
|
Intersect ENT, Inc.
XENT
|
-10.2 | - | - | $ 955 M | ||
|
Abbott Laboratories
ABT
|
30 | $ 110.71 | 0.69 % | $ 193 B | ||
|
Delcath Systems
DCTH
|
121 | $ 9.74 | -0.71 % | $ 349 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
-4.82 | $ 2.6 | 0.39 % | $ 153 M | ||
|
Bio-Rad Laboratories
BIO
|
-10.9 | $ 269.48 | 3.15 % | $ 7.6 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
-271 | $ 9.1 | 1.0 % | $ 701 M | ||
|
AxoGen
AXGN
|
-95.3 | $ 32.75 | -0.27 % | $ 1.51 B | ||
|
Align Technology
ALGN
|
33.1 | $ 176.12 | 3.94 % | $ 13.2 B | ||
|
Bruker Corporation
BRKR
|
0.000061 | $ 33.74 | 2.99 % | $ 5.03 K | ||
|
BioSig Technologies
BSGM
|
-0.707 | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
-12.6 | $ 3.74 | 1.91 % | $ 154 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-11 | $ 17.21 | 0.58 % | $ 404 M |